Sales decline 12.95% to Rs 29.97 crore
Net profit of Kilitch Drugs (India) rose 111.61% to Rs 2.37 crore in the quarter ended December 2022 as against Rs 1.12 crore during the previous quarter ended December 2021. Sales declined 12.95% to Rs 29.97 crore in the quarter ended December 2022 as against Rs 34.43 crore during the previous quarter ended December 2021. ParticularsQuarter EndedDec. 2022Dec. 2021% Var.Sales29.9734.43 -13 OPM %13.282.21 -PBDT3.381.84 84 PBT2.451.64 49 NP2.371.12 112Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
